Cargando…

RV144-like trial in macaques using ALVAC-SIV & gp120 induces innate immunity and increases the frequency of NK22 & NKG2A+ cells in mucosal tissues

Detalles Bibliográficos
Autores principales: Liyanage, NP, Pegu, P, Gordon, S, Cameron, M, Foulds, K, Doster, M, Vaccari, M, Koup, R, Roederer, M, Sékaly, R, Franchini, G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441308/
http://dx.doi.org/10.1186/1742-4690-9-S2-O14
_version_ 1782243261015916544
author Liyanage, NP
Pegu, P
Gordon, S
Cameron, M
Foulds, K
Doster, M
Vaccari, M
Koup, R
Roederer, M
Sékaly, R
Franchini, G
author_facet Liyanage, NP
Pegu, P
Gordon, S
Cameron, M
Foulds, K
Doster, M
Vaccari, M
Koup, R
Roederer, M
Sékaly, R
Franchini, G
author_sort Liyanage, NP
collection PubMed
description
format Online
Article
Text
id pubmed-3441308
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34413082012-09-18 RV144-like trial in macaques using ALVAC-SIV & gp120 induces innate immunity and increases the frequency of NK22 & NKG2A+ cells in mucosal tissues Liyanage, NP Pegu, P Gordon, S Cameron, M Foulds, K Doster, M Vaccari, M Koup, R Roederer, M Sékaly, R Franchini, G Retrovirology Oral Presentation BioMed Central 2012-09-13 /pmc/articles/PMC3441308/ http://dx.doi.org/10.1186/1742-4690-9-S2-O14 Text en Copyright ©2012 Liyanage et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Oral Presentation
Liyanage, NP
Pegu, P
Gordon, S
Cameron, M
Foulds, K
Doster, M
Vaccari, M
Koup, R
Roederer, M
Sékaly, R
Franchini, G
RV144-like trial in macaques using ALVAC-SIV & gp120 induces innate immunity and increases the frequency of NK22 & NKG2A+ cells in mucosal tissues
title RV144-like trial in macaques using ALVAC-SIV & gp120 induces innate immunity and increases the frequency of NK22 & NKG2A+ cells in mucosal tissues
title_full RV144-like trial in macaques using ALVAC-SIV & gp120 induces innate immunity and increases the frequency of NK22 & NKG2A+ cells in mucosal tissues
title_fullStr RV144-like trial in macaques using ALVAC-SIV & gp120 induces innate immunity and increases the frequency of NK22 & NKG2A+ cells in mucosal tissues
title_full_unstemmed RV144-like trial in macaques using ALVAC-SIV & gp120 induces innate immunity and increases the frequency of NK22 & NKG2A+ cells in mucosal tissues
title_short RV144-like trial in macaques using ALVAC-SIV & gp120 induces innate immunity and increases the frequency of NK22 & NKG2A+ cells in mucosal tissues
title_sort rv144-like trial in macaques using alvac-siv & gp120 induces innate immunity and increases the frequency of nk22 & nkg2a+ cells in mucosal tissues
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441308/
http://dx.doi.org/10.1186/1742-4690-9-S2-O14
work_keys_str_mv AT liyanagenp rv144liketrialinmacaquesusingalvacsivgp120inducesinnateimmunityandincreasesthefrequencyofnk22nkg2acellsinmucosaltissues
AT pegup rv144liketrialinmacaquesusingalvacsivgp120inducesinnateimmunityandincreasesthefrequencyofnk22nkg2acellsinmucosaltissues
AT gordons rv144liketrialinmacaquesusingalvacsivgp120inducesinnateimmunityandincreasesthefrequencyofnk22nkg2acellsinmucosaltissues
AT cameronm rv144liketrialinmacaquesusingalvacsivgp120inducesinnateimmunityandincreasesthefrequencyofnk22nkg2acellsinmucosaltissues
AT fouldsk rv144liketrialinmacaquesusingalvacsivgp120inducesinnateimmunityandincreasesthefrequencyofnk22nkg2acellsinmucosaltissues
AT dosterm rv144liketrialinmacaquesusingalvacsivgp120inducesinnateimmunityandincreasesthefrequencyofnk22nkg2acellsinmucosaltissues
AT vaccarim rv144liketrialinmacaquesusingalvacsivgp120inducesinnateimmunityandincreasesthefrequencyofnk22nkg2acellsinmucosaltissues
AT koupr rv144liketrialinmacaquesusingalvacsivgp120inducesinnateimmunityandincreasesthefrequencyofnk22nkg2acellsinmucosaltissues
AT roedererm rv144liketrialinmacaquesusingalvacsivgp120inducesinnateimmunityandincreasesthefrequencyofnk22nkg2acellsinmucosaltissues
AT sekalyr rv144liketrialinmacaquesusingalvacsivgp120inducesinnateimmunityandincreasesthefrequencyofnk22nkg2acellsinmucosaltissues
AT franchinig rv144liketrialinmacaquesusingalvacsivgp120inducesinnateimmunityandincreasesthefrequencyofnk22nkg2acellsinmucosaltissues